Purified vitexin compound 1 induces apoptosis through activation of FOXO3a in hepatocellular carcinoma

Wang,Jian-Gang; Zheng,Xing-Xing; Zeng,Guang-Yao; Zhou,Ying-Jun; Yuan,Hong

doi:10.3892/or.2013.2855

Purified vitexin compound 1 induces apoptosis through activation of FOXO3a in hepatocellular carcinoma

Authors:
- Jian-Gang Wang
- Xing-Xing Zheng
- Guang-Yao Zeng
- Ying-Jun Zhou
- Hong Yuan
View Affiliations

Affiliations: Department of Cardiology, The Third Xiangya Hospital of Central South University, Changsha, Hunan 410013, P.R. China, School of Pharmaceutical Science, Central South University, Changsha, Hunan 410013, P.R. China
Published online on: November 15, 2013 https://doi.org/10.3892/or.2013.2855
Pages: 488-496

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

We previously reported that purified vitexin compound 1 (VB1, a neolignan from the seed of Chinese herb Vitex negundo) exhibited antitumor activity in cancer cell lines and xenograft models. In the present study, we examined the molecular mechanisms by which activation of the FOXO3a transcription factor mediated VB1-induced apoptosis in hepatocellular carcinoma (HCC) cells. The effects of VB1 on the proliferation of HCC cell lines HepG2, Hep3B, Huh-7 and human embryo liver L-02 cells were investigated using the 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) assay. Apoptotic death in HepG2 cells was examined using an enzyme-linked immunosorbent assay (ELISA) detection kit, flow cytometry after propidium iodide (PI) staining, and by DNA agarose gel electrophoresis. Caspase activity was measured using ELISA. The AKT/FOXO3a and ERK/FOXO3a pathways were analyzed using western blotting. VB1 inhibited human HCC cell proliferation in a concentration-dependent manner and increased the percentage of sub-G1 population HepG2 cells. Histone/DNA fragmentation and active caspase-3, -8 and -9 levels increased in a concentration-dependent manner and a DNA ladder was formed. The phosphorylation of AKT and ERK1/2 were inhibited and FOXO3a transcription factor was activated, resulting in apoptotic death. Knockdown of AKT1 by small interfering RNA (siRNA) and the MEK1/2 inhibitor, PD98059, enhanced VB1-induced apoptosis and FOXO3a transcriptional activity. Suppression of FOXO3a expression by siRNA inhibited VB1-induced apoptosis. VB1 induced expression of Bim, TRAIL, DR4 and DR5. Activation of the FOXO3a transcription factor appears to mediate pro-apoptotic effects of VB1 by inhibiting the AKT and ERK pathways.

View Figures

View References

1	Zhu AX: Molecularly targeted therapy for advanced hepatocellular carcinoma in 2012: current status and future perspectives. Semin Oncol. 39:493–502. 2012. View Article : Google Scholar : PubMed/NCBI
2	Siegel R, Naishadham D and Jemal A: Cancer statistics, 2013. CA Cancer J Clin. 63:11–30. 2013. View Article : Google Scholar
3	Padma S, Martinie JB and Iannitti DA: Liver tumor ablation: percutaneous and open approaches. J Surg Oncol. 100:619–634. 2009. View Article : Google Scholar : PubMed/NCBI
4	Ichida T, Van Thiel DH and Hassanein T: The medical management of hepatocellular carcinoma (HCC) in Japan: a review with implications for HCC seen in the west. Hepatogastroenterology. 43:1575–1583. 1996.PubMed/NCBI
5	Bruix J and Sherman M; Practice Guidelines Committee, American Association for the Study of Liver Diseases. Management of hepatocellular carcinoma. Hepatology. 42:1208–1236. 2005. View Article : Google Scholar
6	Llovet JM, Real MI, Montaña X, et al: Arterial embolisation or chemoembolisation versus symptomatic treatment in patients with unresectable hepatocellular carcinoma: a randomised controlled trial. Lancet. 359:1734–1739. 2002. View Article : Google Scholar
7	Choo CY, Sulong NY, Man F and Wong TW: Vitexin and isovitexin from the leaves of Ficus deltoidea with in-vivo α-glucosidase inhibition. J Ethnopharmacol. 142:776–781. 2012. View Article : Google Scholar : PubMed/NCBI
8	Knipping K, Garssen J and van't Land B: An evaluation of the inhibitory effects against rotavirus infection of edible plant extracts. Virol J. 9:1372012. View Article : Google Scholar : PubMed/NCBI
9	Sahreen S, Khan MR and Khan RA: Hepatoprotective effects of methanol extract of Carissa opaca leaves on CCl₄-induced damage in rat. BMC Complement Altern Med. 11:482011. View Article : Google Scholar : PubMed/NCBI
10	Lee CY, Chien YS, Chiu TH, et al: Apoptosis triggered by vitexin in U937 human leukemia cells via a mitochondrial signaling pathway. Oncol Rep. 28:1883–1888. 2012.PubMed/NCBI
11	Papi A, Farabegoli F, Iori R, et al: Vitexin-2-O-xyloside, raphasatin and (−)-epigallocatechin-3-gallate synergistically affect cell growth and apoptosis of colon cancer cells. Food Chem. 138:1521–1530. 2013.PubMed/NCBI
12	Xin H, Kong Y, Wang Y, et al: Lignans extracted from Vitex negundo possess cytotoxic activity by G2/M phase cell cycle arrest and apoptosis induction. Phytomedicine. 20:640–647. 2013.
13	Zhou Y, Liu YE, Cao J, et al: Vitexins, nature-derived lignan compounds, induce apoptosis and suppress tumor growth. Clin Cancer Res. 15:5161–5169. 2009. View Article : Google Scholar : PubMed/NCBI
14	Tan Z and Zhang Y, Deng J, Zeng G and Zhang Y: Purified vitexin compound 1 suppresses tumor growth and induces cell apoptosis in a mouse model of human choriocarcinoma. Int J Gynecol Cancer. 22:360–366. 2012. View Article : Google Scholar : PubMed/NCBI
15	McCubrey JA, Steelman LS, Chappell WH, et al: Mutations and deregulation of Ras/Raf/MEK/ERK and PI3K/PTEN/Akt/mTOR cascades which alter therapy response. Oncotarget. 3:954–987. 2012.PubMed/NCBI
16	Muntané J, De la Rosa AJ, Docobo F, Garcia-Carbonero R and Padillo FJ: Targeting tyrosine kinase receptors in hepatocellular carcinoma. Curr Cancer Drug Targets. 13:300–312. 2013.PubMed/NCBI
17	Cervello M, McCubrey JA, Cusimano A, Lampiasi N, Azzolina A and Montalto G: Targeted therapy for hepatocellular carcinoma: novel agents on the horizon. Oncotarget. 3:236–260. 2012.PubMed/NCBI
18	Cai C, Teng L, Vu D, et al: The heme oxygenase 1 inducer (CoPP) protects human cardiac stem cells against apoptosis through activation of the extracellular signal-regulated kinase (ERK)/NRF2 signaling pathway and cytokine release. J Biol Chem. 287:33720–33732. 2012. View Article : Google Scholar
19	Xu X, Fan Z, Kang L, et al: Hepatitis B virus X protein represses miRNA-148a to enhance tumorigenesis. J Clin Invest. 123:630–645. 2013.PubMed/NCBI
20	Yang JY and Hung MC: Deciphering the role of forkhead transcription factors in cancer therapy. Curr Drug Targets. 12:1284–1290. 2011. View Article : Google Scholar : PubMed/NCBI
21	Arden KC: Multiple roles of FOXO transcription factors in mammalian cells point to multiple roles in cancer. Exp Gerontol. 41:709–717. 2006. View Article : Google Scholar : PubMed/NCBI
22	Hu MC, Lee DF, Xia W, et al: IκB kinase promotes tumorigenesis through inhibition of forkhead FOXO3a. Cell. 117:225–237. 2004.
23	Potente M, Urbich C, Sasaki K, et al: Involvement of Foxo transcription factors in angiogenesis and postnatal neovascularization. J Clin Invest. 115:2382–2392. 2005. View Article : Google Scholar : PubMed/NCBI
24	Brunet A, Bonni A, Zigmond MJ, et al: Akt promotes cell survival by phosphorylating and inhibiting a Forkhead transcription factor. Cell. 96:857–868. 1999. View Article : Google Scholar : PubMed/NCBI
25	Yang JY, Zong CS, Xia W, et al: ERK promotes tumorigenesis by inhibiting FOXO3a via MDM2-mediated degradation. Nat Cell Biol. 10:138–148. 2008. View Article : Google Scholar : PubMed/NCBI
26	Kim SH, Jeong JH, Kim TI, Kim SW and Bull DA: VEGF siRNA delivery system using arginine-grafted bioreducible poly(disulfide amine). Mol Pharm. 6:718–726. 2009. View Article : Google Scholar : PubMed/NCBI
27	Du J, Gao S, Luo J, et al: Effective inhibition of foot-and-mouth disease virus (FMDV) replication in vitro by vector-delivered microRNAs targeting the 3D gene. Virol J. 8:2922011. View Article : Google Scholar : PubMed/NCBI
28	Guerrero AD, Schmitz I, Chen M and Wang J: Promotion of caspase activation by caspase-9-mediated feedback amplification of mitochondrial damage. J Clin Cell Immunol. 3:pii: 1000126. 2012. View Article : Google Scholar : PubMed/NCBI
29	Ranjan K, Surolia A and Pathak C: Apoptotic potential of Fas-associated death domain on regulation of cell death regulatory protein cFLIP and death receptor mediated apoptosis in HEK 293T cells. J Cell Commun Signal. 6:155–168. 2012. View Article : Google Scholar : PubMed/NCBI
30	Yamasaki Y, Yamasaki M, Tachibana H and Yamada K: Important role of β1-integrin in fucoidan-induced apoptosis via caspase-8 activation. Biosci Biotechnol Biochem. 76:1163–1168. 2012.
31	Kornblau SM, Singh N, Qiu Y, Chen W, Zhang N and Coombes KR: Highly phosphorylated FOXO3A is an adverse prognostic factor in acute myeloid leukemia. Clin Cancer Res. 16:1865–1874. 2010. View Article : Google Scholar : PubMed/NCBI
32	Vadlakonda L, Pasupuleti M and Pallu R: Role of PI3K-AKT-mTOR and Wnt signaling pathways in transition of G1-S phase of cell cycle in cancer cells. Front Oncol. 3:852013. View Article : Google Scholar : PubMed/NCBI
33	Pardo PS, Lopez MA and Boriek AM: FOXO transcription factors are mechanosensitive and their regulation is altered with aging in the respiratory pump. Am J Physiol Cell Physiol. 294:C1056–C1066. 2008. View Article : Google Scholar : PubMed/NCBI
34	Nho RS, Hergert P, Kahm J, Jessurun J and Henke C: Pathological alteration of FoxO3a activity promotes idiopathic pulmonary fibrosis fibroblast proliferation on type I collagen matrix. Am J Pathol. 179:2420–2430. 2011. View Article : Google Scholar
35	Wang X, Chen WR and Xing D: A pathway from JNK through decreased ERK and Akt activities for FOXO3a nuclear translocation in response to UV irradiation. J Cell Physiol. 227:1168–1178. 2012. View Article : Google Scholar : PubMed/NCBI
36	Xie C, Song LB, Wu JH, et al: Upregulator of cell proliferation predicts poor prognosis in hepatocellular carcinoma and contributes to hepatocarcinogenesis by downregulating FOXO3a. PLoS One. 7:e406072012. View Article : Google Scholar : PubMed/NCBI
37	Ghosh AP, Klocke BJ, Ballestas ME and Roth KA: CHOP potentially co-operates with FOXO3a in neuronal cells to regulate PUMA and BIM expression in response to ER stress. PLoS One. 7:e395862012. View Article : Google Scholar : PubMed/NCBI
38	Zhao XC, Cao XC, Liu F, Quan MF, Ren KQ and Cao JG: Regulation of the FOXO3a/Bim signaling pathway by 5,7-dihydroxy-8-nitrochrysin in MDA-MB-453 breast cancer cells. Oncol Lett. 5:929–934. 2013.PubMed/NCBI
39	Cunha DA, Igoillo-Esteve M, Gurzov EN, et al: Death protein 5 and p53-upregulated modulator of apoptosis mediate the endoplasmic reticulum stress-mitochondrial dialog triggering lipotoxic rodent and human β-cell apoptosis. Diabetes. 61:2763–2775. 2012.PubMed/NCBI
40	He L, Yang X, Cao X, Liu F, Quan M and Cao J: Casticin induces growth suppression and cell cycle arrest through activation of FOXO3a in hepatocellular carcinoma. Oncol Rep. 29:103–108. 2013.PubMed/NCBI
41	Chen Q, Ganapathy S, Singh KP, Shankar S and Srivastava RK: Resveratrol induces growth arrest and apoptosis through activation of FOXO transcription factors in prostate cancer cells. PLoS One. 5:e152882010. View Article : Google Scholar : PubMed/NCBI
42	Boreddy SR, Pramanik KC and Srivastava SK: Pancreatic tumor suppression by benzyl isothiocyanate is associated with inhibition of PI3K/AKT/FOXO pathway. Clin Cancer Res. 17:1784–1795. 2011. View Article : Google Scholar : PubMed/NCBI
43	Roy SK, Srivastava RK and Shankar S: Inhibition of PI3K/AKT and MAPK/ERK pathways causes activation of FOXO transcription factor, leading to cell cycle arrest and apoptosis in pancreatic cancer. J Mol Signal. 5:102010. View Article : Google Scholar : PubMed/NCBI
44	Shankar S, Marsh L and Srivastava RK: EGCG inhibits growth of human pancreatic tumors orthotopically implanted in Balb C nude mice through modulation of FKHRL1/FOXO3a and neuropilin. Mol Cell Biochem. 372:83–94. 2013. View Article : Google Scholar : PubMed/NCBI
45	Srivastava RK, Unterman TG and Shankar S: FOXO transcription factors and VEGF neutralizing antibody enhance antiangiogenic effects of resveratrol. Mol Cell Biochem. 337:201–212. 2010. View Article : Google Scholar : PubMed/NCBI